Who owns Bio-Rad Laboratories (BIO)? Superinvestor holders
3 superinvestors of the 157 tracked here hold Bio-Rad Laboratories (BIO) in their latest 13F filing, with $1.3B between them. John Rogers gives it the most weight: 3.10% of the reported portfolio. In their latest reported quarter, John Rogers, Matthew McLennan and Steven Romick reduced.
Mason Hawkins sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 3 of 157
- Biggest holder
- Matthew McLennan, $927.5M
- Largest weight
- John Rogers, 3.10%of their portfolio
- Combined value
- $1.3B
- Bought last quarter
- 0
- Sold last quarter
- 4
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | John RogersAriel Investments | 3.10% | $298.1M | 789.34K | ▼ Reduced 3.4% | −27.44K | Q3 2026 |
| 2 | Matthew McLennanFirst Eagle Investment Management | 1.46% | $927.5M | 2.46M | ▼ Reduced 5.8% | −150.64K | Q3 2026 |
| 3 | Steven RomickFirst Pacific Advisors (FPA) | 1.21% | $101.6M | 269.08K | ▼ Reduced 33% | −132.77K | Q3 2026 |
Sold out last quarter
- Mason Hawkinswas $45.4M · Q2 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 3 | 3.51M | $1.3B | 0 | 3 |
| Q2 2026 | 157 | 3 | 3.82M | $1.1B | 2 | 2 |
| Q1 2026 | 157 | 4 | 3.96M | $1.1B | 3 | 2 |
| Q4 2025 | 157 | 5 | 4.01M | $1.2B | 2 | 4 |
| Q3 2025 | 157 | 7 | 4.14M | $1.2B | 5 | 2 |
| Q2 2025 | 157 | 5 | 4.04M | $975.1M | 4 | 1 |
| Q1 2025 | 156 | 4 | 2.99M | $727.6M | 4 | 1 |
| Q4 2024 | 156 | 6 | 2.03M | $667.8M | 2 | 3 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Matthew McLennan | 2.46M | 2.61M | 2.6M | 2.57M | 2.52M | 2.52M | 1.57M | 713.51K |
| John Rogers | 789.34K | 816.75K | 785.96K | 764.67K | 809.48K | 818.62K | 724.66K | 560.52K |
| Steven Romick | 269.08K | 401.86K | 407.36K | 401.46K | 394.41K | 386.95K | 372.56K | 157.85K |
| Mason Hawkins | · | — | 162.8K | 227.63K | 237.25K | 315.29K | 323.81K | 308.47K |
| Louis Bacon | — | — | — | 50K | 55K | — | — | 45K |
| Joel Greenblatt | · | — | — | — | 124.63K | — | — | — |
| Quentin Koffey | · | — | — | — | 3.02K | 2.59K | — | — |
| Steve Cohen | · | — | — | — | — | — | — | 247.51K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own BIO?
In their latest 13F filings: John Rogers (3.10% of the portfolio, $298.1M), Matthew McLennan (1.46% of the portfolio, $927.5M), Steven Romick (1.21% of the portfolio, $101.6M).
Who sold BIO last quarter?
Reduced: John Rogers (3.4% fewer shares), Matthew McLennan (5.8% fewer shares), Steven Romick (33% fewer shares). Sold out entirely: Mason Hawkins (was $45.4M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Bio-Rad Laboratories (BIO)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/BIO/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to BIO by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.